Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients

被引:8
作者
Leomil Coelho, Luiz Felipe
de Oliveira, Jaquelline Germano
de Oliveira, Danilo Bretas
Martins Guedes, Antonio Carlos
Duarte Lanna, Cristina Costa
Prados, Roberto Zimmer
Peregrino Ferreira, Paulo Cesar
Bonjardim, Claudio Antonio
Kroon, Erna Geessien
机构
[1] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270910 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
[3] Hosp Balcia, Dept Cirurgia Plastica, Belo Horizonte, MG, Brazil
[4] Univ Fed Piaui, Ctr Ciencias Suade, Dept Microbiol & Parasitol, Microbiol Lab, Piaui, Brazil
关键词
interferon; PKR; 2'5'OAS; fibroblast; affected skin; systemic sclerosis;
D O I
10.1007/s00403-007-0737-x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Scleroderma or systemic sclerosis (SSc) is an autoimmune disorder of unknown aetiology characterized by excessive collagen synthesis and subsequent deposition on the skin and various internal organs. Interferons (IFNs) are well-known immunomodulators and inhibitors of collagen production. However, IFN therapy has been implicated in the development or exacerbation of several autoimmune diseases, including SSc. We analyzed the expression of several interferon-stimulated genes (ISGs) in affected skin of SSc patients (skin tissue and cultured skin fibroblasts). A set of ISGs (PKR, 2'5'OAS, MxA, and 6-16) was analyzed by real-time PCR using RNA extracted from cultured skin fibroblasts and skin tissue of normal individuals and SSc patients. Both normal and SSc affected skin cultured fibroblasts were sensitive to the IFN treatment and presented similar levels of all ISGs tested. However, PKR and 2'5'OAS mRNA expression levels were significantly higher in the affected skin tissue of SSc patients when compared to normal controls. These data suggest that the IFN system plays a role in the pathogenesis of SSc.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 19 条
[1]   Systemic sclerosis: Another rheumatic disease associated with hepatitis C virus infection [J].
Abu-Shakra, M ;
Sukenik, S ;
Buskila, D .
CLINICAL RHEUMATOLOGY, 2000, 19 (05) :378-380
[2]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[3]   Interferons as pathogenic effectors in autoimmunity [J].
Baccala, R ;
Kono, DH ;
Theofilopoulos, AN .
IMMUNOLOGICAL REVIEWS, 2005, 204 :9-26
[4]   Autoimmunity through cytokine-induced dendritic cell activation [J].
Banchereau, J ;
Pascual, V ;
Palucka, AK .
IMMUNITY, 2004, 20 (05) :539-550
[5]   Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders [J].
Beretta, L ;
Caronni, M ;
Vanoli, M ;
Scorza, R .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) :385-386
[6]   Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses - and viruses counteract IFN action [J].
Bonjardim, CA .
MICROBES AND INFECTION, 2005, 7 (03) :569-578
[7]   Culture of human amniotic cells: A system to study interferon production [J].
Carvalho, AF ;
Santos, JR ;
Gentz, R ;
Bonjardim, CA ;
Golgher, RR ;
Ferreira, PCP ;
Kroon, EG .
PLACENTA, 1998, 19 (04) :307-314
[8]   Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis [J].
Chawla-Sarkar, M ;
Lindner, DJ ;
Liu, YF ;
Williams, B ;
Sen, GC ;
Silverman, RH ;
Borden, EC .
APOPTOSIS, 2003, 8 (03) :237-249
[9]  
de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
[10]   Scleroderma - clinical and pathological advances [J].
Denton, CP ;
Black, CM .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (03) :271-290